Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 -0.0686M
June 30, 2026 -0.6499M
March 31, 2026 0.00
December 31, 2025 0.002M
September 30, 2025 -0.0115M
June 30, 2025 -0.0908M
March 31, 2025 -0.042M
December 31, 2024 -0.0361M
September 30, 2024 -0.0126M
June 30, 2024 -0.142M
March 31, 2024 -0.103M
December 31, 2023 -1.489M
September 30, 2023 -0.4446M
June 30, 2023 -0.7769M
March 31, 2023 -0.048M
December 31, 2022 -0.1554M
September 30, 2022 -0.1166M
June 30, 2022 -0.1563M
March 31, 2022 -0.022M
December 31, 2021 -0.3042M
September 30, 2021 -0.2039M
June 30, 2021 0.00
March 31, 2021 -0.048M
December 31, 2020 -0.054M
September 30, 2020 -0.083M
Date Value
June 30, 2020 -0.046M
March 31, 2020 -0.022M
December 31, 2019 -0.1051M
September 30, 2019 -0.2449M
June 30, 2019 -0.068M
March 31, 2019 -0.123M
December 31, 2018 -1.251M
September 30, 2018 -0.1457M
June 30, 2018 -0.0947M
March 31, 2018 -0.181M
December 31, 2017 -0.3363M
September 30, 2017 -0.6884M
June 30, 2017 -0.2515M
March 31, 2017 -2.399M
December 31, 2016 -2.625M
September 30, 2016 -8.532M
June 30, 2016 -4.819M
March 31, 2016 -0.238M
December 31, 2015 -0.9718M
September 30, 2015 -0.3248M
June 30, 2015 -0.0395M
March 31, 2015 -0.028M
December 31, 2014 -0.0215M
September 30, 2014 -0.0952M
June 30, 2014 -0.3271M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Alkermes Plc 19.99M
Amarin Corp. Plc 4.556M
Agenus, Inc. -19.88M
Amgen, Inc. -649.00M
Anika Therapeutics, Inc. -1.756M